Correspondence

Management of a drug–drug interaction between BRAF inhibitors and combined antiretroviral therapy in a HIV-infected patient with craniopharyngioma

Lagoutte-Renosi, Jennifer^a,b; Karsenty, Judith^c; Martha, Benoît^c; Davani, Siamak^a,b; Muret, Patrice^b

^aEA 3920 Université de Franche-Comté

^bService de Pharmacologie Clinique et Toxicologie, CHU de Besançon, Besançon

^cService de maladies infectieuses, Centre Hospitalier William Morey, Chalon sur Saône, France.

Correspondence to Jennifer Lagoutte-Renosi, CHU de Besançon, Service de Pharmacologie Clinique et Toxicologie, 3, Boulevard Fleming, 25030 Besançon Cedex, France. Tel: +33 0 3 70 63 23 79; fax: +33 0 3 70 63 21 05; e-mail: [email protected]

Received 24 August, 2022

Revised 19 January, 2023

Accepted 10 February, 2023

AIDS 37(7):p 1181-1183, June 1, 2023. | DOI: 10.1097/QAD.0000000000003527

Secondary Logo

Journal Logo

Management of a drug–drug interaction between BRAF inhibitors and combined antiretroviral therapy in a HIV-infected patient with craniopharyngioma

Full Text Access for Subscribers:

Institutional Users

Not a Subscriber?

Related Links

Article Level Metrics

Related Videos

Readers Of this Article Also Read

Management of a drug–drug interaction between BRAF inhibitors and combined antiretroviral therapy in a HIV-infected patient with craniopharyngioma : AIDS

Full Text Access for Subscribers:

Individual Subscribers

Institutional Users

Not a Subscriber?